miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3

Open Access

Peer-reviewed

Research Article

Rounak Nassirpour,

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America
⨯
Pramod P. Mehta,

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America
⨯
Min-Jean Yin

* E-mail: min-jean.yin@pfizer.com

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America
⨯

Reader Comments (0)

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cell migration
Is the Subject Area "Cell migration" applicable to this article?

Thanks for your feedback.
3' UTR
Is the Subject Area "3' UTR" applicable to this article?

Thanks for your feedback.
Carcinogenesis
Is the Subject Area "Carcinogenesis" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.